Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer

por Bottini, A, Berruti, A, Brizzi, M P, Bersiga, A, Generali, D, Allevi, G, Aguggini, S, Bolsi, G, Bonardi, S, Bertoli, G, Alquati, P, Dogliotti, L
Publicado 2003

Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma

por Comella, P, Farris, A, Lorusso, V, Palmeri, S, Maiorino, L, Lucia, L De, Buzzi, F, Mancarella, S, Vita, F De, Gambardella, A
Publicado 2003

Minichromosome maintenance (Mcm) proteins, cyclin B1 and D1, phosphohistone H3 and in situ DNA replication for functional analysis of vulval intraepithelial neoplasia

por Davidson, E J, Morris, L S, Scott, I S, Rushbrook, S M, Bird, K, Laskey, R A, Wilson, G E, Kitchener, H C, Coleman, N, Stern, P L
Publicado 2003

Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-α-based isolated hepatic perfusion

por van Etten, B, de Vries, M R, van IJken, M G A, Lans, T E, Guetens, G, Ambagtsheer, G, van Tiel, S T, de Boeck, G, de Bruijn, E A, Eggermont, A M M, ten Hagen, T L M
Publicado 2003

Methylation status of p14ARF and p16INK4a as detected in pancreatic secretions

por Klump, B, Hsieh, C J, Nehls, O, Dette, S, Holzmann, K, Kießlich, R, Jung, M, Sinn, U, Ortner, M, Porschen, R, Gregor, M
Publicado 2003

Expression level of integrin α5 on tumour cells affects the rate of metastasis to the kidney

por Tani, N, Higashiyama, S, Kawaguchi, N, Madarame, J, Ota, I, Ito, Y, Ohoka, Y, Shiosaka, S, Takada, Y, Matsuura, N
Publicado 2003

Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2

por De Paola, F, Ridolfi, R, Riccobon, A, Flamini, E, Barzanti, F, Granato, A M, Mordenti, G L, Medri, L, Vitali, P, Amadori, D
Publicado 2003

Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen

por Kupryjańczyk, J, Szymańska, T, Mądry, R, Timorek, A, Stelmachów, J, Karpińska, G, Rembiszewska, A, Ziółkowska, I, Kraszewska, E, Dębniak, J, Emerich, J, Ułańska, M, Płużańska, A, Jędryka, M, Goluda, M, Chudecka-Głaz, A, Rzepka-Górska, I, Klimek, M, Urbański, K, Bręborowicz, J, Zieliński, J, Markowska, J
Publicado 2003

Prognostic value of maspin mRNA expression in ERα-positive postmenopausal breast carcinomas

por Bièche, I, Girault, I, Sabourin, J-C, Tozlu, S, Driouch, K, Vidaud, M, Lidereau, R
Publicado 2003

IDN 5390: an oral taxane candidate for protracted treatment schedules

por Pratesi, G, Laccabue, D, Lanzi, C, Cassinelli, G, Supino, R, Zucchetti, M, Frapolli, R, D'Incalci, M, Bombardelli, E, Morazzoni, P, Riva, A, Zunino, F
Publicado 2003

Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity

por de Bruin, M, van Capel, T, Van der Born, K, Kruyt, F A, Fukushima, M, Hoekman, K, Pinedo, H M, Peters, G J
Publicado 2003

CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia

por Tayeb, M T, Clark, C, Haites, N E, Sharp, L, Murray, G I, McLeod, H L
Publicado 2003

Elevated expression and altered processing of fibulin-1 protein in human breast cancer

por Greene, L M, Twal, W O, Duffy, M J, McDermott, E W, Hill, A D, O'Higgins, N J, McCann, A H, Dervan, P A, Argraves, W S, Gallagher, W M
Publicado 2003

Analysis of the time course and prognostic factors determining toxicity due to infused fluorouracil

por Tebbutt, N C, Norman, A R, Cunningham, D, Allen, M, Chau, I, Oates, J, Hill, M
Publicado 2003

A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs

por Spooner, R A, Friedlos, F, Maycroft, K, Stribbling, S M, Roussel, J, Brueggen, J, Stolz, B, O'Reilly, T, Wood, J, Matter, A, Marais, R, Springer, C J
Publicado 2003

Cytology vs molecular analysis for the detection of head and neck squamous cell carcinoma in oesopharyngeal brush samples: a prospective study in 56 patients

por Temam, S, Trassard, M, Leroux, G, Bosq, J, Luboinski, B, Lenoir, G, Bénard, J, Janot, F
Publicado 2003

Phase II multicentre study of docetaxel plus 5-fluorouracil in patients with anthracycline-pretreated metastatic breast cancer

por Lortholary, A, Delozier, T, Monnier, A, Bourgeois, H, Bougnoux, P, Tubiana-Mathieu, N, Riffaud, J Ch, Besson, D, Lotz, V, Gamelin, E
Publicado 2003

Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer

por Lorusso, V, Crucitta, E, Silvestris, N, Catino, A, Caporusso, L, Mazzei, A, Guida, M, Latorre, A, Sambiasi, D, D'Amico, C, Schittulli, F, Calabrese, P, De Lena, M
Publicado 2003

hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and d...

por Fletcher, G C, Patel, S, Tyson, K, Adam, P J, Schenker, M, Loader, J A, Daviet, L, Legrain, P, Parekh, R, Harris, A L, Terrett, J A
Publicado 2003

Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer

por Pelosi, G, Pastorino, U, Pasini, F, Maissoneuve, P, Fraggetta, F, lannucci, A, Sonzogni, A, De Manzoni, G, Terzi, A, Durante, E, Bresaola, E, Pezzella, F, Viale, G
Publicado 2003